Source: Associated Press via Yahoo! News
Posted: July 28, 2006 1:07 pm ET
Summary:
(AP) -- A Singapore biotech company-ES Cell International-announced it has produced and stored six new human embryonic stem cell lines suitable for use in clinical trials and expects to store another two in the next five weeks.
Alan Colman, chief executive of ES Cell International, said the company is the first to create human embryonic stem cells (hESC) under the strict standards imposed for clinical use in humans, and that the lines will be available to researchers worldwide by the end of the year.
Commentary: Hopefully this announcement will accelerate the pace of embryonic stem cell research and eventually lead to the development of new treatments for diseases, injuries and other medical conditions.
No comments:
Post a Comment